miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a.

MLA

Cao, Man-Qing, et al. “MiR-182-5p Promotes Hepatocellular Carcinoma Progression by Repressing FOXO3a.” Journal of Hematology & Oncology, vol. 11, Jan. 2018, p. 1–N.PAG. EBSCOhost, https://doi.org/10.1186/s13045-018-0555-y.

APA

Cao, M.-Q., You, A.-B., Zhu, X.-D., Zhang, W., Zhang, Y.-Y., Zhang, S.-Z., Zhang, K., Cai, H., Shi, W.-K., Li, X.-L., Li, K.-S., Gao, D.-M., Ma, D.-N., Ye, B.-G., Wang, C.-H., Qin, C.-D., Sun, H.-C., Zhang, T., & Tang, Z.-Y. (2018). miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a. Journal of Hematology & Oncology, 11, 1–N.PAG. https://doi.org/10.1186/s13045-018-0555-y

Chicago

Cao, Man-Qing, A-Bin You, Xiao-Dong Zhu, Wei Zhang, Yuan-Yuan Zhang, Shi-Zhe Zhang, Ke-wei Zhang, et al. 2018. “MiR-182-5p Promotes Hepatocellular Carcinoma Progression by Repressing FOXO3a.” Journal of Hematology & Oncology 11 (January): 1–N.PAG. doi:10.1186/s13045-018-0555-y.